155 related articles for article (PubMed ID: 22106003)
21. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
[TBL] [Abstract][Full Text] [Related]
22. Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group.
Matloub Y; Rabin KR; Ji L; Devidas M; Hitzler J; Xu X; Bostrom BC; Stork LC; Winick N; Gastier-Foster JM; Heerema NA; Stonerock E; Carroll WL; Hunger SP; Gaynon PS
Blood Adv; 2019 Jun; 3(11):1647-1656. PubMed ID: 31160295
[TBL] [Abstract][Full Text] [Related]
23. Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group.
Goto H; Inukai T; Inoue H; Ogawa C; Fukushima T; Yabe M; Kikuchi A; Koike K; Fukushima K; Isoyama K; Saito T; Ohara A; Hanada R; Iwamoto J; Hotta N; Nagatoshi Y; Okamura J; Tsuchida M
Int J Hematol; 2011 Feb; 93(2):192-198. PubMed ID: 21286878
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children.
Saarinen-Pihkala UM; Lanning M; Perkkiö M; Mäkipernaa A; Salmi TT; Hovi L; Vettenranta K
Med Pediatr Oncol; 2000 May; 34(5):319-27. PubMed ID: 10797353
[TBL] [Abstract][Full Text] [Related]
25. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
[TBL] [Abstract][Full Text] [Related]
26. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
[TBL] [Abstract][Full Text] [Related]
27. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
Rajantie J; Siimes MA
J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.
Buitenkamp TD; Mathôt RA; de Haas V; Pieters R; Zwaan CM
Haematologica; 2010 Jul; 95(7):1106-13. PubMed ID: 20418240
[TBL] [Abstract][Full Text] [Related]
29. Increases of sICAM-1 during neutropenic pneumonia in leukemic patients.
Südhoff T; Wehmeier A; Arning M; Bauser U; Schlömer P; Aul C; Schneider W
Leukemia; 1997 Mar; 11(3):346-51. PubMed ID: 9067572
[TBL] [Abstract][Full Text] [Related]
30. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
[TBL] [Abstract][Full Text] [Related]
31. Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia.
Valle M; Plon SE; Rabin KR
Leuk Res; 2009 Feb; 33(2):336-9. PubMed ID: 18718659
[TBL] [Abstract][Full Text] [Related]
32. Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Matsushima S; Kobayashi R; Sano H; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Pediatr Blood Cancer; 2021 Feb; 68(2):e28763. PubMed ID: 33047887
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia.
Clarke V; Dunstan FD; Webb DK
Med Pediatr Oncol; 1999 May; 32(5):331-5. PubMed ID: 10219333
[TBL] [Abstract][Full Text] [Related]
34. Oral Mucositis in Pediatric Acute Lymphoblastic Leukemia Patients: Evaluation of Microbiological and Hematological Factors.
Mendonça RM; Araújo Md; Levy CE; Morari J; Silva RA; Yunes JA; Brandalise SR
Pediatr Hematol Oncol; 2015; 32(5):322-30. PubMed ID: 26086683
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.
Hefti E; Blanco JG
J Pediatr Hematol Oncol; 2016 May; 38(4):283-7. PubMed ID: 26907658
[TBL] [Abstract][Full Text] [Related]
36. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review.
Maloney KW
Br J Haematol; 2011 Nov; 155(4):420-5. PubMed ID: 21933171
[TBL] [Abstract][Full Text] [Related]
37. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
[TBL] [Abstract][Full Text] [Related]
38. Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?
Schmiegelow K; Nersting J; Nielsen SN; Heyman M; Wesenberg F; Kristinsson J; Vettenranta K; Schrøeder H; Weinshilboum R; Jensen KL; Grell K; Rosthoej S
Pediatr Blood Cancer; 2016 Dec; 63(12):2104-2111. PubMed ID: 27447547
[TBL] [Abstract][Full Text] [Related]
39. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the approaches to non-febrile neutropenia developing in children with acute lymphoblastic leukemia.
Paksu MS; Paksu S; Akbalik M; Ozyurek E; Duru F; Albayrak D; Fisgin T
Fundam Clin Pharmacol; 2012 Jun; 26(3):418-23. PubMed ID: 21395681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
